References
- Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 1991;75(3):388–393. doi:https://doi.org/10.1097/00000542-199109000-00002.
- Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004;30(10):1873–1881. doi:https://doi.org/10.1007/s00134-004-2388-0.
- Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002;106(23):2881–2883. doi:https://doi.org/10.1161/01.CIR.0000043806.51912.9B.
- White SK, Frohlich GM, Sado DM, Maestrini V, Fontana M, Treibel TA, Tehrani S, Flett AS, Meier P, Ariti C, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2015;8(1 Pt B):178–188. doi:https://doi.org/10.1016/j.jcin.2014.05.015.
- Candilio L, Malik A, Ariti C, Barnard M, Di Salvo C, Lawrence D, Hayward M, Yap J, Roberts N, Sheikh A, et al. Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart 2015;101(3):185–192. doi:https://doi.org/10.1136/heartjnl-2014-306178.
- Cho YJ, Lee EH, Lee K, Kim TK, Hong DM, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, et al. Long-term clinical outcomes of remote ischemic preconditioning and postconditioning outcome (RISPO) trial in patients undergoing cardiac surgery. Int J Cardiol 2017;231:84–89. doi:https://doi.org/10.1016/j.ijcard.2016.12.146.
- Hausenloy DJ, Kharbanda RK, Moller UK, Ramlall M, Aaroe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, et al. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial. Lancet 2019;394(10207):1415–1424.
- Linden MD, Whittaker P, Frelinger AL 3rd, Barnard MR, Michelson AD, Przyklenk K. Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation. J Thromb Haemost 2006;4(12):2670–2677. doi:https://doi.org/10.1111/j.1538-7836.2006.02228.x.
- Pedersen CM, Cruden NL, Schmidt MR, Lau C, Botker HE, Kharbanda RK, Newby DE. Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J Thromb Haemost 2011;9(2):404–407. doi:https://doi.org/10.1111/j.1538-7836.2010.04142.x.
- Battipaglia I, Scalone G, Milo M, Di Franco A, Lanza GA, Crea F. Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease. Heart 2011;97(16):1298–1303. doi:https://doi.org/10.1136/hrt.2011.226415.
- Weerasinghe A. Taylor KM: the platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66(6):2145–2152. doi:https://doi.org/10.1016/S0003-4975(98)00749-8.
- Kondo C, Tanaka K, Takagi K, Shimono T, Shinpo H, Yada I, Yuasa H, Kusagawa M, Akamatsu N, Tanoue K. Platelet dysfunction during cardiopulmonary bypass surgery. With special reference to platelet membrane glycoproteins. Asaio J 1993;39(3):M550–553.
- Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996;87(12):4925–4936. doi:https://doi.org/10.1182/blood.V87.12.4925.bloodjournal87124925.
- Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999;6(5):342–348. doi:https://doi.org/10.1097/00062752-199909000-00012.
- Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104(13):1533–1537. doi:https://doi.org/10.1161/hc3801.095588.
- Lu Q, Malinauskas RA. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood. Artif Organs 2011;35(2):137–144.
- Rosenberg JH, Werner JH, Moulton MJ, Agrawal DK. Current modalities and mechanisms underlying cardioprotection by ischemic conditioning. J Cardiovasc Transl Res 2018;11(4):292–307. doi:https://doi.org/10.1007/s12265-018-9813-1.
- Kharbanda RK, Li J, Konstantinov IE, Cheung MM, White PA, Frndova H, Stokoe J, Cox P, Vogel M, Van Arsdell G, et al. Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study. Heart 2006;92(10):1506–1511. doi:https://doi.org/10.1136/hrt.2004.042366.
- Shimizu M, Tropak M, Diaz RJ, Suto F, Surendra H, Kuzmin E, Li J, Gross G, Wilson GJ, Callahan J, et al. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond) 2009;117(5):191–200. doi:https://doi.org/10.1042/CS20080523.
- Cho YJ, Kim WH. Perioperative cardioprotection by remote ischemic conditioning. Int J Mol Sci 2019;20(19):4839. doi:https://doi.org/10.3390/ijms20194839.
- Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375(9716):727–734. doi:https://doi.org/10.1016/S0140-6736(09)62001-8.
- Jin X, Wang L, Li L, Zhao X. Protective effect of remote ischemic pre-conditioning on patients undergoing cardiac bypass valve replacement surgery: A randomized controlled trial. Exp Ther Med 2019;17(3):2099–2106.
- Xu Y, Huo Y, Toufektsian MC, Ramos SI, Ma Y, Tejani AD, French BA, Yang Z. Activated platelets contribute importantly to myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2006;290(2):H692–699. doi:https://doi.org/10.1152/ajpheart.00634.2005.
- Mirabet M, Garcia-Dorado D, Inserte J, Barrabes JA, Lidon RM, Soriano B, Azevedo M, Padilla F, Agullo L, Ruiz-Meana M, et al. Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts. Am J Physiol Heart Circ Physiol 2002;283(3):H1134–1141. doi:https://doi.org/10.1152/ajpheart.00065.2002.
- Rosenberg RD, Aird WC. Vascular-bed–specific hemostasis and hypercoagulable states. N Engl J Med 1999;340(20):1555–1564. doi:https://doi.org/10.1056/NEJM199905203402007.
- Hata K, Whittaker P, Kloner RA, Przyklenk K. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation 1998;97(7):692–702. doi:https://doi.org/10.1161/01.CIR.97.7.692.
- Stazi A, Scalone G, Laurito M, Milo M, Pelargonio G, Narducci ML, Parrinello R, Figliozzi S, Bencardino G, Perna F, et al. Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation. Circulation 2014;129(1):11–17. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.005336.
- Cho YJ, Nam K, Kim TK, Choi SW, Kim SJ, Hausenloy DJ, Jeon Y. Sevoflurane, propofol and carvedilol block myocardial protection by limb remote ischemic preconditioning. Int J Mol Sci 2019;20(2):269. doi:https://doi.org/10.3390/ijms20020269.
- Behmenburg F, van Caster P, Bunte S, Brandenburger T, Heinen A, Hollmann MW, Huhn R. Impact of anesthetic regimen on remote ischemic preconditioning in the rat heart in vivo. Anesth Analg 2018;126(4):1377–1380. doi:https://doi.org/10.1213/ANE.0000000000002563.
- Kottenberg E, Musiolik J, Thielmann M, Jakob H, Peters J, Heusch G. Interference of propofol with signal transducer and activator of transcription 5 activation and cardioprotection by remote ischemic preconditioning during coronary artery bypass grafting. J Thorac Cardiovasc Surg 2014;147(1):376–382. doi:https://doi.org/10.1016/j.jtcvs.2013.01.005.
- Hausenloy DJ, Botker HE. Why did remote ischaemic conditioning not improve clinical outcomes in acute myocardial infarction in the CONDI-2/ERIC-PPCI trial? Cardiovasc Res 2019;115(14):e161–e163.
- Pinaud F, Corbeau JJ, Baufreton C, Binuani JP, De Brux JL, Fouquet O, Angoulvant D, Furber A, Prunier F. Remote ischemic preconditioning in aortic valve surgery: results of a randomized controlled study. J Cardiol 2016;67(1):36–41. doi:https://doi.org/10.1016/j.jjcc.2015.06.007.
- Rubens FD, Labow RS, Waghray G, Robblee J. The importance of sampling site in the measurement of whole-blood platelet flow cytometry. J Cardiothorac Vasc Anesth 1998;12(3):309–313. doi:https://doi.org/10.1016/S1053-0770(98)90012-X.
- Rondina MT, Grissom CK, Men S, Harris ES, Schwertz H, Zimmerman GA, Weyrich AS. Whole blood flow cytometry measurements of in vivo platelet activation in critically-Ill patients are influenced by variability in blood sampling techniques. Thromb Res 2012;129(6):729–735. doi:https://doi.org/10.1016/j.thromres.2011.11.031.
- Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 2014;66(4):1142–1174. doi:https://doi.org/10.1124/pr.113.008300.
- Miki T, Itoh T, Sunaga D, Miura T. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 2012;11:67. doi:https://doi.org/10.1186/1475-2840-11-67.